Financhill
Back

Eliem Therapeutics Quote, Financials, Valuation and Earnings

Sell
45

ELYM
Eliem Therapeutics

Last Price:
8.25
Seasonality Move:
-25.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Eliem Therapeutics Price Quote

$8.25

Eliem Therapeutics Key Stats

Sell
45
Eliem Therapeutics (ELYM) is a Sell

Day range:
$7.76 - $8.61
52-week range:
$2.34 - $11.55
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.26%

Volume:
318.6K
Avg. volume:
1.8M
1-year change:
191.52%
Market cap:
$240M
Revenue:
$0
EPS:
$-0.53

How Much Does Eliem Therapeutics Make?

Data Unavailable

Is Eliem Therapeutics Growing As A Company?

Data Unavailable

Eliem Therapeutics Stock Price Performance

What Is Eliem Therapeutics 52-Week High & Low?

Eliem Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Eliem Therapeutics?

Is Eliem Therapeutics Cash Flow Positive?

  • What Is ELYM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$7.2M
  • What Is Eliem Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $855K
  • What Is Eliem Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $76.9M

Eliem Therapeutics Return On Invested Capital

Data Unavailable

Eliem Therapeutics Earnings Date & Stock Price

Eliem Therapeutics Competitors

  • Who Are Eliem Therapeutics's Competitors?
    Below is a list of companies who compete with Eliem Therapeutics or are related in some way:
    • Alpine Immune Sciences Inc (ALPN)
    • Candel Therapeutics Inc (CADL)
    • Cyclacel Pharmaceuticals Inc (CYCC)
    • GlycoMimetics Inc (GLYC)
    • Lipocine Inc (LPCN)

Eliem Therapeutics Dividend Yield

Data Unavailable

Eliem Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 4.00
Downside from Last Price: -51.52%

Major Shareholders

  • How many ELYM shares are owned by institutional investors?
    30.4M ELYM shares are owned by institutional investors
  • How many ELYM shares are owned by insiders?
    683.4K ELYM shares are owned by insiders